By PRISM Posted January 25, 2017 In bp2016.12017-01-252017-01-25https://prism.org.au/wp-content/uploads/2016/11/prism_banner800x150.jpgPsychedelic Research in Science & Medicinehttps://prism.org.au/wp-content/uploads/2016/11/prism_banner800x150.jpg200px200px Recent PostsPsychedelic Support and Harm Reduction5-MeO-DMT: A primer on a potent psychedelicPRISM’s Response: TGA Rescheduling of Psilocybin and MDMA Independent Expert Review Panel ReportPRISM’s Response: TGA Rescheduling of Psilocybin and MDMA Independent Expert Review Panel Report
